Changes in geometry and cortical porosity in adult, ovary-intact rabbits after 5 months treatment with LY333334 (hPTH 1-34)

Calcified Tissue International

Volumn 66, Issue 6, 2000, Pages 456-460

  Hirano, T ^a   Burr, D B ^a   Cain, R L ^b   Hock, J M ^b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b ELI LILLY AND COMPANY   (United States)

Author keywords

Cortical porosity; Cross sectional moment of inertia; Mechanical strength; Osteoporosis; PTH

Indexed keywords

PARATHYROID HORMONE[1-34];

ANIMAL EXPERIMENT; ARTICLE; BONE STRENGTH; BONE STRUCTURE; CONTROLLED STUDY; CORTICAL BONE; DOSE RESPONSE; DRUG EFFECT; FEMALE; FEMUR; NONHUMAN; OSTEOPOROSIS; POROSITY; PRIORITY JOURNAL; RABBIT; RIGIDITY; TIBIA;

EID: 0034043906     PISSN: 0171967X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002230010091     Document Type: Article

References (31)

1. Gunness-Hey M, Hock JM (1984) Increased trabecular bone mass in rats treated with human synthetic parathyroid hormone. Metab Bone Dis Rel Res 5:177-81
2. Liu C-C, Kalu DN (1990) Human parathyroid hormone (1-34) prevents bone loss and augments bone formation in sexually mature ovariectomized rats. J Bone Miner Res 4:449-458
3. Shen V, Dempster DW, Birchman R, Xu R, Lindsay R (1993) Loss of cancellous bone mass and connectivity in ovariectomized rats can be restored by combined treatment with parathyroid hormone and estradiol. J Clin Invest 91:2479-2487
4. Ejersted C, Andreassen TT, Oxlund H, Jorgensen PH, Bak B, Haggblad J, Torring O, Nilsson MH (1993) Human parathyroid hormone (1-34) and (1-84) increase the mechanical strength and thickness of cortical bone in rats. J Bone Miner Res 8:1097-1101
5. Oxlund H, Ejersted C, Andreassen TT, Torring O, Nilsson MH (1993) Parathyroid hormone (1-34) and (1-84) stimulate cortical bone formation both from periosteum and endosteum. Calcif Tissue Int 53:394-399
6. Wronski TJ, Yen CF (1994) Anabolic effects of parathyroid hormone on cortical bone in ovariectomized rats. Bone 15: 51-58
7. Baumann BD, Wronski TJ (1995) Response of cortical bone to antiresorptive agents and parathyroid hormone in aged ovariectomized rats. Bone 16:247-253
8. Mosekilde L, Danielsen CC, Sogaard CH, McOsker JE, Wronski TJ (1995) The anabolic effects of parathyroid hormone on cortical bone mass, dimensions and strength-assessed in a sexually mature, ovariectomized rat model. Bone 16:223-230
9. Podbesek R, Edouard C, Meunier PJ, Parsons JA, Reeve J, Stevenson RW, Zanelli JM (1983) Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds. Endocrinology 112:1000-1006
10. Mackey MS, Stevens ML, Ebert DC, Tressler DL, Combs KS, Lowry CK, Smith PN, McOsker JE (1995) The ferret as a small animal model with BMU-based remodeling for skeletal research. Bone 17:191S-196S
11. Jerome CP, Johnson CS, Lees CJ (1995) Effect of treatment for 3 months with human parathyroid hormone 1-34 peptide in ovariectomized cynomolgus monkeys (Macaca fascicularis). Bone 17:415S-420S
12. Reeve J, Meunier PJ, Parsons JA, Bernat M, Bijvoet OL, Courpron P, Edouard C, Klenerman L, Neer RM, Renier JC, Slovik D, Vismans FJ, Potts Jr JT (1980) Anabolic effect of human parathyroid hormone fragment on trabecular bone in involutional osteoporosis: a multicentre trial. Br Med J 280: 1340-1344
13. Hesp R, Hulme P, Williams D, Reeve J (1981) The relationship between changes in femoral bone density and calcium balance in patients with involutional osteoporosis treated with human parathyroid hormone fragment (hPTH 1-34). Metab Bone Dis Rel Res 2:331-334
14. Slovik DM, Rosenthal DI, Doppelt SH, Potts Jr JT, Daly MA, Campbell JA, Neer RM (1986) Restoration of spinal bone in osteoporotic men by treatment with human parathyroid hormone (1-34) and 1,25-dihydroxyvitamin D. J Bone Miner Res 1:377-381
15. Reeve J, Davies UM, Hesp R, McNally E, Katz D (1990) Treatment of osteoporosis with human parathyroid peptide and observations on effect of sodium fluoride. BMJ 301:314-318
16. Hodsman AB, Steer MB, Fraher LJ, Drost DJ (1991) Bone densitometric and histomorphometric responses to sequential human parathyroid hormone (1-38) and salmon calcitonin in osteoporotic patients. Bone Miner 14:67-83
17. Neer M, Slovik DM, Daly N, Potts Jr JT, Nussbaum SR (1993) Treatment of postmenopausal osteoporosis with daily parathyroid hormone plus calcitriol. Osteoporos Int 3:S204-S205
18. Sone T, Fukunaga M, Ono S, Nishiyama T (1995) A small dose of human parathyroid hormone (1-34) increased bone mass in the lumbar vertebrae in patients with senile osteoporosis. Miner Electrolyte Metab 21:232-235
19. Hodsman AB, Fraher LJ, Watson PH, Ostbye T, Stilt LW, Adachi JD, Taves DH, Drost D (1997) A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis. J Clin Endocrinol Metab 82:620-628
20. Lindsay R, Nieves J, Formica C, Henneman E, Woelfert L, Shen V, Dempster D (1997) Randomised controlled study of effect of parathyroid hormone on vertebral bone mass and fracture incidence among postmenopausal women on estrogen with osteoporosis. Lancet 350:551-555
21. Inoue J (1985) Bone changes with long-term administration of low doses of 1-34 human PTH in adult beagles. J Jpn Ortho Assn 59:409-427
22. 3 or risedronate on endosteal bone remodeling in canine cancellous and cortical bone. J Bone Miner Res 11:600-613
23. Sietsema WK (1995) Animal models of cortical porosity. Bone 17:297S-305S
24. Turner CH, Burr DB (1993) Basic biomechanical measurements of bone: a tutorial. Bone 14:595-608
25. Roberts WE, Turley PK, Brezniak N, Fielder PJ (1987) Implants: bone physiology and metabolism. CDA J 15:54-61
26. Turner CH, Takano Y, Hirano T (1996) Reductions in bone strength after fluoride treatment are not reflected in tissue-level acoustic measurements. Bone 19:603-607
27. Hirano T, Burr DB, Turner CH, Sato M, Cain RL, Hock JM (1999) Anabolic effects of human biosynthetic parathyroid hormone fragment (1-34), LY333334, on remodeling and mechanical properties of cortical bone in rabbits. J Bone Miner Res 14:536-545
28. Vradenburg M, Metcalfe A, Dietrich J, MacLachlan R, Smith SY, Bare S, Kimmel DB (1997) Dose effects of parathyroid hormone (1-84) on bone formation and porosity in cortical bone of rhesus monkeys. J Bone Miner Res 12:S236
29. Ejersted C, Oxlund H, Andreassen TT (1998) Bisphosphonate maintains parathyroid hormone (1-34)-induced cortical bone mass and mechanical strength in rats. Calcif Tissue Int 62: 316-322
30. Oxlund H, Ejersted C, Andreassen TT, Torring O, Nilsson MHL (1993) Parathyroid hormone (1-34) and (1-84) stimulate cortical bone formation both from periosteum and endosteum. Calcif Tissue Int 53:394-399
31. Wronski TJ, Yen C-F (1994) Anabolic effects of parathyroid hormone on cortical bone in ovariectomized rats. Bone 15: 51-58